AX048
AX048 is an inhibitor for calcium-dependent phospholipase A2 cPLA2 with a XI (50) of 0.022 mole fraction and reveals an antihyperalgesic efficacy[1].
Product Specifications
CAS Number
873079-69-7
UNSPSC
12352211
Target
Phospholipase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ax048.html
Solubility
10 mM in DMSO
Smiles
O=C(C(CCCCCCCCCCCCCC)=O)NCCCC(OCC)=O
Molecular Formula
C22H41NO4
Molecular Weight
383.57
References & Citations
[1]Yaksh TL, et al., Systemic and intrathecal effects of a novel series of phospholipase A2 inhibitors on hyperalgesia and spinal prostaglandin E2 release. J Pharmacol Exp Ther. 2006 Jan;316 (1) :466-75.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Phospholipase A
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1201591-01 0.02 mg (E-Coli)
Recombinant Actinobacillus pleuropneumoniae serotype 3 N-acetylneuraminate lyase (nanA)
Sign In for Pricing
View Details MBS1201591-02 0.02 mg (Yeast)
Recombinant Actinobacillus pleuropneumoniae serotype 3 N-acetylneuraminate lyase (nanA)
Sign In for Pricing
View Details MBS1201591-03 0.1 mg (E-Coli)
Recombinant Actinobacillus pleuropneumoniae serotype 3 N-acetylneuraminate lyase (nanA)
Sign In for Pricing
View Details MBS1201591-04 0.1 mg (Yeast)
Recombinant Actinobacillus pleuropneumoniae serotype 3 N-acetylneuraminate lyase (nanA)
Sign In for Pricing
View Details MBS1201591-05 0.02 mg (Baculovirus)
Recombinant Actinobacillus pleuropneumoniae serotype 3 N-acetylneuraminate lyase (nanA)
Sign In for Pricing
View Details